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Abstract 
Age-associated thymic involution is characterized by decreased thymopoiesis, adipocyte 
deposition and changes in the expression of various thymic microenvironmental factors. In 
this work, we characterized the distribution of fat-storing cells within the aging thymus. We 
found an increase of unilocular adipocytes, ERTR7
+ and CCR5
+ fat-storing multilocular cells 
in the thymic septa and parenchymal regions, thus suggesting that mesenchymal cells could 
be immigrating and differentiating in the aging thymus. We verified that the expression of 
CCR5 and its ligands, CCL3, CCL4 and CCL5, were increased in the thymus with age. Hy-
pothesizing that the increased expression of chemokines and the CCR5 receptor may play a 
role in adipocyte recruitment and/or differentiation within the aging thymus, we examined 
the potential role for CCR5 signaling on adipocyte physiology using 3T3-L1 pre-adipocyte 
cell line. Increased expression of the adipocyte differentiation markers, PPARγ2 and aP2 in 
3T3-L1 cells was observed under treatment with CCR5 ligands. Moreover, 3T3-L1 cells 
demonstrated an ability to migrate in vitro in response to CCR5 ligands. We believe that the 
increased presence of fat-storing cells expressing CCR5 within the aging thymus strongly 
suggests that these cells may be an active component of the thymic stromal cell compart-
ment in the physiology of thymic aging. Moreover, we found that adipocyte differentiation 
appear to be influenced by the proinflammatory chemokines, CCL3, CCL4 and CCL5. 
Key words: thymus, aging, adipocyte, differentiation, chemokines, chemotaxis, involution, adi-
pokines 
Introduction 
The adipose tissue is the principal fat reservoir in 
the body. Unilocular adipocytes are the principal 
component of white adipose tissue and have a classi-
cal role in the regulation of triglycerides and fatty acid 
accumulation during energy expenditure and depri-
vation (1-2). The regulation of adipocyte differentia-
tion is controlled by several factors, including hor-
mones and their receptors that activate proteins and 
transcription factors such as CEBP/β, PPAR-γ, 
CEBP/α, aP2 and others (3-4). Besides unilocular Int. J. Med. Sci. 2010, 7 
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adipocytes, mesenchymal stem cells and differentiat-
ing adipocytes have been described in the adipose 
tissue making it appear that mesenchymal stem cells 
under specific stimuli become committed to the adi-
pocyte lineage and able to accumulating lipids thus 
forming adipocytic multilocular cells, preadipocytes, 
and ultimately, unilocular adipocytes (1-4).   
More recently, several groups have demon-
strated that adipose tissue is able to produce proin-
flammatory cytokines and fat-derived peptides 
termed adipokines (including ligands such as adi-
ponectin, leptin, resistin, TNF-α, IL-6), which act in a 
paracrine, autocrine and/or endocrine manner (4-5). 
The accumulation of adipocytic cells and an increased 
percentage of fat in several ectopic regions of the body 
with aging have been well-described (6). This increase 
also appears to correlate with observed increases in 
circulating levels of proinflammatory cytokines dur-
ing aging (7). This is of great interest from an immu-
nological perspective, as the thymus is one of the or-
gans known to accumulate fat during aging and has 
been shown to be sensitive to inflammatory changes 
(8-10). 
  The thymus is a primary lymphoid organ re-
sponsible for the differentiation and maturation of T 
lymphocytes (10-12). Anatomically, it is a bi-lobed 
organ subdivided in lobules by septa that emerge 
from the capsule. Blood vessels and nerves are able to 
reach the thymic parenchyma by the septa region. In 
the young thymus, each lobule contains two very well 
defined regions: the cortex, enriched in immature T 
cells; and the medulla, where mainly mature im-
munocompetent thymocytes can be found, before 
exiting the organ to populate the periphery. The 
process of T cell maturation initiates during fetal de-
velopment. In post-natal life, progenitors that origi-
nated in the bone marrow enter into the thymus and 
interact with several different thymic stromal cell 
types, including epithelial cells, macrophages, den-
dritic cells and fibroblasts, which participate of the T 
cell differentiation process (10-12). With age, the 
thymus gradually decreases its capacity to generate 
immunocompetent T cells and becomes minimally 
functional, as it undergoes dramatic changes in its 
size, morphology and cell composition, a process 
termed “age-associated thymic involution” (8-10, 
13-16). Decreased thymopoiesis, loss of cortical and 
medullary boundaries, deposition of unilocular adi-
pocytes and changes in the expression of various 
thymic factors have been shown to occur during this 
process. This is associated with the increased suscep-
tibility of aged individuals to infectious diseases (10, 
17). Thus, investigating the mechanisms that regulate 
thymic involution and identifying the cells that par-
ticipate in this process might contribute to the devel-
opment of strategic therapies for immunodeficiency 
conditions, as in the case of aging.  
 In the current studies, we have investigated the 
distribution of fat-storing cells in the aging thymus 
and we found not only an increase of unilocular adi-
pocytes but also an increase of adipocytic-like multi-
locular mesenchymal cells in the septa and paren-
chymal regions of the organ. These findings suggest 
that adipocyte precursors or fat-storing cells may be 
migrating into and/or differentiating actively within 
the aging thymic microenvironment. Furthermore, we 
found that the adipocyte-like cells accumulating in the 
thymus with age express the chemokine receptor, 
CCR5. Using the well-characterized adipocytic mes-
enchymal cell line, 3T3-L1, we found that CCR5 
ligands are capable of regulating the migration and 
differentiation of these cells and suggest a potential 
role for these chemokines in adipocyte biology. 
Material and Methods 
Mice. BALB/c mice bred in the National Institute 
on Aging rodent colony (Bethesda, MD) were utilized 
at 2, 4, 6, 9, 12, 18, 21 and 24 month-old. Mice were 
housed in environmentally controlled rooms with a 
12h light-dark cycle according to the procedures out-
lined in the "Guide for the Care and Use of Laboratory 
Animals" [NIH publication no.  86-23, 1985]. 
CCR5-deficient mice (B6;129P2-Ccr5tm1Kuz/J) originally 
obtained from Jackson Laboratories (Bar Harbor, ME) 
were aged in the animal house of the NIAID and 
kindly donated by Dr. Alan Sher (NIAID/NIH). 
cDNA microarray. 1,152 cDNA clones were se-
lected from a verified sequence master set containing 
15,000 human T1 phage-negative IMAGE Consortium 
clones commercially obtained from Research Genet-
ics, Inc. (Huntsville,  AL). Nylon membranes were 
used as substrate for denatured cDNA clone printing 
in duplicates, using a GMS417 Microarrayer  (Affy-
metrix, Santa Clara, CA). Before the addition of the 
cDNA probe, the thymi of 2-, 4-, 6-, 12- and 
18-month-old BALB/c mice were placed into multiple 
pools by age for total RNA extraction using RNAzol B 
(Tel-Test, Friendswood, TX) and cDNA probes were 
prepared using reverse transcriptase. cDNA mi-
croarray membranes were loaded into conical tubes 
containing Mycrohyb hybridization buffer (Research 
Genetics) in presence of 0.6μg/μl of Cot1 DNA (Life 
Technologies) and 0.5μg/μl of poly A primers (Sigma) 
blocking agents. Tubes were rotated at 42
°C for 180 
min. After prehybridization, 33P-labeled cDNA probes 
(at the concentration of 1x106 counts/ml hybridization 
buffer) were added to the tubes with cDNA microar-
ray membranes and hybridized overnight at 42
°C. Int. J. Med. Sci. 2010, 7 
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Hybridized membranes were washed twice with 15 
ml of wash solution (0.1%SDS and 2x SSC) for 15 min 
at 55
°C and at room temperature, respectively. The 
radioactive cDNA microarray membranes were ex-
amined on a phosphorimager (Molecular Dynamics 
Storm, Sunnyvale, CA) at a resolution of 50 μm. Grid 
overlays were utilized to identify cDNA targets on the 
arrays and signal intensity for each cDNA was ex-
amined using the Array Pro software (Media Cyber-
netics, Silver Spring, MD). Background correction for 
each cDNA microarray hybridization assay was as-
sessed via the subtraction of single spot intensities by 
the median of the background signal intensity from 
the array. The background-subtracted spot intensities 
were subsequently transformed to loge scale and ratio 
comparisons were done using the group of 2 
month-old as control.  
Real time RT-PCR. 1 μg of total RNA isolated 
from the thymi of 2-, 12- or 18-month-old BALB/c 
m i c e  w a s  u t i l i z e d  t o  g e n e r a t e  c D N A  p r o b e s  u s i n g  
Taqman Reverse Transcription Reagents (PE Applied 
Biosystems, Foster City, CA). The SYBR Green I assay 
and the GeneAmp 5700 Sequence Detection System 
(PE Applied Biosystems) were utilized for the detec-
tion of real-time PCR products as previously de-
scribed (18). Primers were designed for CCR5, CCL3, 
CCL4 and CCL5 based on their sequence in GenBank 
(www.ncbi.nlm.nih.gov/GenBank) as well as for 
glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), which was utilized as control. For each of 
the age groups, PCR reactions were performed in du-
plicate in a 96-well plate for each gene-specific primer 
pair tested. The comparative threshold cycle  (CT) 
method (PE Applied Biosystems) was utilized to de-
termine relative quantity of gene expression for each 
gene compared with the GAPDH control. Briefly, CT 
values from GAPDH reactions were averaged for each 
duplicate and the relative difference between GAPDH 
and each duplicate was calculated (2 CT GAPDH - CT 
experimental). This value was then averaged for each 
duplicate set and divided by the value of the 2 
month-old thymus samples to determine the relative 
fold induction for each sample. Differences regarding 
fold change values observed between the cDNA mi-
croarray and real-time PCR results might be due to 
experimental variability in the two distinct assays. 
Tissue Array and Immunohistochemistry. Thymi 
(n=4) of 2, 9, 12, 18 and 21 months of age were 
mounted in a tissue array as previously described 
(19). For hematoxylin and eosin staining, sections 
were deparaffinized in xylene, re-hydrated in graded 
alcohols and placed at high temperature in solution of 
0.01 M sodium citrate buffer (pH 6.0) for 40 min. Sec-
tions were then stained with hematoxylin (Lerner 
Laboratories), rinsed and differentiated with 1% 
acidic alcohol before eosin (Lerner Laboratories, 
Pittsburgh, PA) staining, dehydrated in graded alco-
hol and then mounted in organic media. For peroxi-
dase immunohistochemistry, a standard two-step 
Dako Autostainer (Dako Corporation, Carpenteria, 
CA) was utilized to examine the thymic sections. An 
antigen retrieval procedure was utilized to recover 
antigenic sites from tissue sections. Primary purified 
rabbit anti-mouse CCR5 (BD PharMingen, CA), rabbit 
anti-CCL3, -CCL4 (R&D Systems, MN) or -CCL5 
(Chemicon, CA) IgG antibodies were applied on 
thymic sections at 10μg/ml for 60 min at room tem-
perature in moist humidified chamber. After exten-
sive washing, tissue sections were incubated with 
peroxidase-conjugated donkey anti-goat, goat 
anti-rabbit or rabbit anti-rat (Santa Cruz Biotechnol-
ogies) antibody, for 30 min, after which the sections 
were extensively washed and then immersed in a 
freshly prepared chromogen/substrate reagent (dia-
minobenzidine, DAB/ Hydrogen peroxide, H2O2). 
Slides were mounted using an organic media (Cyto-
sealTM60, Stephens Scientific, Riverdale, NJ). PBS, pH 
7.4, was used for all intermediate wash steps.  
For immunofluorescence, rat anti-mouse fibro-
blast/ mesenchymal cells (ER-TR7) (Novus Biologi-
cals, Littleton, CO) IgG antibody was used at 10μg/ml 
for 60 min. After PBS washing, slides were incubated 
with anti-rat IgG antibody conjugated to Alexa-594 
(Molecular Probes, Eugene, OR). Subsequently, slides 
were washed, incubated with the DNA dye DAPI 
(4',6-diamidino-2-phenylindole) and mounted using 
glycerol 50% aqueous mounting media.  
Oil Red O staining. Oil red O (Fischer Scientific, 
Hanover Park, IL) was diluted in 50% propylene gly-
col, and filtered. Thymic tissue sections were incu-
bated with Oil Red O solution for 4h at room tem-
perature and then rinsed with 50% isopropyl alcohol 
and in distilled water before hematoxylin staining, for 
2 min. Slides were then rinsed with ammonia 5% in 
water, blot dried and mounted with glycerol 50% 
aqueous mounting media.  
Cultures of 3T3-L1 preadipocytes for differen-
tiation analysis. Cells were cultured in Dulbecco’s 
minimal essential medium (DMEM) supplemented 
with 10% calf serum until confluence (6-7 days). Then, 
confluent 3T3-L1 preadipocytes were treated for 9 or 
1 2  d a y s  w i t h  1 0 0  n g  o f  C C L 3 ,  C C L 4  o r  C C L 5  
(Chemicon, CA). Culture medium was changed every 
three days. Subsequently, differentiation of 3T3-L1 
cells was analyzed by lipid accumulation under light 
microscope and by western blot analysis for adipocyte 
differentiation markers.  
Western Blot analysis. 3T3-L1 cells were lysed in Int. J. Med. Sci. 2010, 7 
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1.5x Laemlli sample buffer and proteins were quanti-
tated by Bradford reagent (Bio-Rad, Hercules, CA). 
After heating for 5 min at 95°C, proteins were sepa-
rated by SDS-PAGE on 12% polyacrylamide gel and 
transferred onto 0.22μm polyvinylidine (difluoride) 
membranes (Invitrogen). Membranes were probed 
with rabbit anti-PPARγ2 (Affinity BioReagents, CO) 
or rabbit-anti-aP2 (GeneTex, TX) antibodies. Signal 
detection was performed by chemiluminescence 
(ECL) using Hyperfilm (Amersham Biosciences).  
Migration assay. 3T3-L1 preadipocytes were 
placed in fibronectin-coated plates (BD Biosciences, 
CA) in DMEM medium. After two days 
post-confluence, cells were treated in the absence or in 
the presence of CCL3, CCL4 or CCL5 (100 ng/ml) for 
16h. A wound was inflicted with a sterile plastic tip by 
scratching the confluent monolayer. Cells moving into 
the scratch were observed over several time points 
using light microscopy. 
Results 
Fat-storing multilocular cells increase within 
the thymus with advancing age. Tissue arrays were 
used to characterize the phenotype of adipocytic cells 
within the thymus of aging mice. Histological and 
morphological analyses indicated an age-dependent 
increase in adipose tissue deposition, including 
unilocular adipocytes and multilocular cells. Upper 
panels of Figure 1 represent the thymus of 2, 12 and 21 
month-old mice stained for hematoxylin and eosin. In 
the thymus of 2 month-old mice the cortical and me-
dullary regions were well-defined and very few or no 
adipocytes were observed in the septa region or inside 
the organ (Figure 1A). A progressive deposition of 
unilocular adipocytes was mainly seen in the thymic 
perivascular space (PVS), as shown in the representa-
tive photomicrography of 12 month-old murine thy-
mus (Figure 1B). Interestingly, in some thymic tissue 
sections of 18 month-old animals, isolated adipocytes 
were observed in the subcapsulary region of the organ 
(not shown) and fibroblastoid cells were visualized 
inside the thymic parenchyma. These fibroblastoid 
cells were observed connected to the capsule, thus 
creating a boundary-like structure in the subcapsulary 
region of the organ (Figure 3H). As expected, as 
thymus aged, a decrease in the number of thymocytes 
was seen in the cortex and loss of cortical and me-
dullary boundaries were observed in the thymic lob-
ules (Figure 1).  
To further investigate the presence of fat-storing 
cells in the aging thymus, we performed Oil Red O 
staining in frozen mouse thymic tissues. Increased 
number of multilocular Oil Red O+ cells was observed 
inside the thymus with aging (Figure 1 D-I). While the 
thymi of 2 month-old mice showed few, if any, Oil 
Red O+ multilocular cells, mice at 4 and 6 months of 
age presented fat-storing cells mainly in the septa 
region of the organ (not shown). Moreover, Oil Red 
O+  multilocular cells were observed in the thymic 
septa and in the thymic capsular regions of 12 
month-old mice. Finally, a higher number of Oil Red 
O+ multilocular cells were visualized in the septa re-
gion and inside the thymic parenchyma of 12 and 24 
month-old thymi (Figure 1). These data lead us to 
propose that adipocytic/mesenchymal cells may be 
migrating to the aging thymus and behaving as a 
thymic stromal cell component able to interact closely 
with differentiating thymocytes and other microen-
vironmental cells in the aging thymus. 
Age-dependent thymic expression of CCR5 
chemokine receptor. Based on the possibility that 
adipocytic/mesenchymal cells could be immigrating 
into the thymus, we looked for genes that significantly 
changed with age and are known to be involved in 
cell migration. Using cDNA microarray technology, 
changes in thymic gene expression profiles were 
analyzed as a feature of aging. One of the genes iden-
tified was CCR5, a chemokine receptor known to bind 
to the proinflammatory chemokines CCL3, CCL4 and 
CCL5. Previous data have demonstrated that CCR5 
participates in T cell migration and activation (20). In 
addition, CCR5 has been shown to be expressed in T 
cells, macrophages and, interestingly, human adipo-
cytes and 3T3L1 preadipocyte cell line (21-23). We 
analyzed the expression of CCR5 mRNA and found 
that it was increased in the aging thymus, as detected 
by cDNA microarray and confirmed by real time 
RT/PCR (Figure 2). Flow cytometric analyses re-
vealed that only 1 to 2% of total mouse thymocytes 
express CCR5, independently of age (data not shown), 
indicating that this increase may be attributable to 
CCR5 production by thymic stromal cells. Int. J. Med. Sci. 2010, 7 
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Figure 1. Increase of fat-storing cells within the murine thymus with advancing age. Photomicrographs of 
thymus paraffin sections (5μm) derived from mice of distinct ages were stained with hematoxylin and eosin (A-C). 
Fat-storing multilocular cells were stained with Oil Red O (red) and hematoxylin following cryosection of thymic tissue 
(D-F). A and D, B and E and C and F are representative photomicrographs for groups of mice with 2, 12 and more than 18 
months of age, respectively. In G and H, fat-storing multilocular cells (red) are shown in the capsule, septa and inside the 
parenchyma of mice with 12 months of age. (I) shows zoom of marked region in figure H with fat-storing multilocular cells 
contacting thymocytes in the thymic subcapsulary region. Ca, capsule; s, septa; c, cortex; m, medulla; bv, blood vessel, P, 
parenchyma. Original magnification: 400x (A,B,C); 1000x (D,E,F); 630x (G,H,I).  
 
Figure 2. CCR5 mRNA expression in 
the aging thymus. (A) cDNA microarray 
filters hybridized to total RNA isolated 
from thymi between 2 and 18 months of 
age. Arrows indicate spot corresponding 
to CCR5 mRNA expression. (B) Graphic 
representation of CCR5 mRNA expres-
sion according to cDNA microarray re-
sults for thymus of 2, 4, 6, 12 and 18 
months of age. (C) CCR5 mRNA expres-
sion of thymus of 2, 12 and 18 months old 
was compared using real time RT/PCR 
analysis.  
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CCR5 expression in the aging thymus is mainly 
detected in fat-storing multilocular cells. To sub-
stantiate the above observations, we performed im-
munohistochemical analysis of our thymic tissue ar-
ray and demonstrated an increase of CCR5 expression 
in the aging thymus (Figure 3). Although some thy-
mocytes stained positive for CCR5 were observed, the 
main thymic cell type expressing CCR5 resembled 
adipocytic-like multilocular cells or fat-storing cells. 
These cells were mainly found in the septa region, 
adjacent to adipocytes, and also in the thymic paren-
chyma, interacting with thymocytes and thymic mi-
croenvironmental cells (Figure 3). Morphologically, 
CCR5+ multilocular cells and fibroblastoid cells were 
present in the perithymic adipose tissue as well as in 
the perivascular space in the septa and capsule. Ad-
ditionally, these cells were visualized in the subcap-
sulary region of aged thymi and inside the thymic 
aged parenchyma in contact with thymocytes (Figures 
3). Serial sections of thymic tissue arrays showed that 
these multilocular cells stained positively for ER-TR7, 
a known marker for murine mesenchymal cells (Fig-
ure 4).   
Expression of CCR5 ligands is enhanced in the 
aging thymus. To further investigate a possible role 
for CCR5 on immigration of fat-storing cells, we ex-
amined the expression of CCR5 ligands in the aging 
thymus. Real time-RT-PCR analysis showed that the 
expression of CCL3, CCL4 and CCL5 mRNA in-
creased in thymus and total thymocytes with age 
(Figure 5). Using immunohistochemical method, 
thymocytes and thymic stromal cells stained posi-
tively for CCL4 and CCL5 (Figure 6). Interestingly, in 
the septa region of the thymus of 2 month-old mice, 
CCL4 expression was detected in cells resembling 
pericytes and myofibroblasts, mesenchymal cell types 
(Figure 6). In the thymus of 12 months of age, CCL4 
expression was observed in thymocytes and in mul-
tilocular cells in the septa and inside the thymic pa-
renchyma. These data reinforced the hypothesis that 
adipocytic mesenchymal cells could be possibly im-
migrating and/or differentiating in the aging thymus 
by an active process regulated by CCR5 ligands. 
Intrathymic fat-storing cells are present in aged 
CCR5-deficient mice. The possibility that CCR5 
ligands could be influencing immigration of adipo-
cytic mesenchymal cells into the aging thymus lead us 
to investigate whether Oil Red O+ cells could be visu-
alized in thymi of 10-11 month-old CCR5-deficient 
mice. Both aged CCR5-deficient mice and wild type 
control group presented Oil Red O+ multilocular cells 
in the septa and in the cortical region of the thymus 
(Figure 7). Although the number of Oil Red O+ cells in 
CCR5-deficient mice was lower than in control group, 
this difference was not statistically significant. More-
over, there was no significant histological change 
between CCR5-deficient and control thymi stained for 
hematoxylin and eosin (data not shown).  
CCR5 ligands regulate differentiation and mi-
gration of 3T3-L1 adipocytic multilocular mesen-
chymal cells in vitro. Due to the lack of specific sur-
face markers for adipocytic multilocular mesenchy-
mal cells and technical difficulties to isolate them, we 
chose to analyze the effects of CCR5 ligands in murine 
3T3-L1 cells, a well-characterized embryonic mesen-
chymal cell line known to differentiate into adipocytes 
in vitro (24,25). To investigate the role of CCR5 ligands 
in 3T3-L1 cells, immunocytochemistry was used to 
verify the expression of ER-TR7 and CCR5. The re-
sults confirmed that preadipocytes in culture express 
CCR5 (Figure 8A). In addition, 3T3-L1 cells in differ-
entiation also expressed CCL3, CCL4 and CCL5, thus 
suggesting that these chemokines could possibly act 
in an autocrine and paracrine manner (Figure 8A).   
The differentiation of 3T3-L1 cells is routinely 
carried out by the addition of dexamethasone, insulin 
and isobutyl-methyl-xanthine to the culture medium 
(24,25). However, in the absence of these specific fac-
tors, 3T3-L1 cells are able to differentiate spontane-
ously although to a much slower rate. To analyze if 
CCR5 ligands would be able to stimulate differentia-
tion of 3T3-L1 cells to adipocytes, CCL3, CCL4 or 
CCL5 was added to the culture medium of confluent 
cells for nine or twelve days. These chemokines were 
found to stimulate the differentiation of 3T3-L1 cells, 
as evidenced by the increase expression of the adipo-
cyte differentiation markers, PPARγ2 and aP2 (Figure 
8B). By the ninth day of culture, the number of re-
fringent multilocular cells accumulating lipids was 
higher in CCR5 ligand-treated cells when compared 
to untreated cells. This observation was even more 
evident at twelve days of culture (Figure 8C).  
We also investigated the influence of CCL3, 
CCL4 and CCL5 on the migration of multilocular 
mesenchymal cells in vitro. 3T3-L1 cells were cultured 
in fibronectin coated-plates and two days 
post-confluence, cells were treated with CCL3, CCL4 
or CCL5 for 20h, followed by scratching of the plate. 
As indicated in figure 9A, after 20h, higher cell motil-
ity was observed in the plates treated with all three 
CCR5 ligands, as compared to untreated cells, and the 
treatment of CCL5 elicited the strongest effect. Taken 
together, these results show that CCR5 ligands are 
able to modulate adipocyte differentiation as well as 
the migration of 3T3-L1 adipocytes. 
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Figure 3. CCR5 expression in histological thymic sections of aging mice. Thymus sections of mice with 2, 9, 12 
and 18 months of age were submitted to immunoperoxidase using rabbit anti-mouse CCR5 Ab (A-G) or unspecific rabbit 
IgG (H). Counterstaining was done with hematoxylin. CCR5 was detected in multilocular cells in the septa, parenchyma and 
adipose tissue (C-G) as well as in thymocytes (F). Black arrows indicate CCR5
+ mesenchymal cells in the perithymic adipose 
tissue (B). White arrows point to fibroblastoid cells originating from the thymic capsule (H). A, adipocyte; Ca, capsule; C, 
cortex; M, medulla; P, parenchyma; S, septa; mo, months of age. Original magnification: 630x (left) and 1000x (right). Int. J. Med. Sci. 2010, 7 
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Figure 4. Expression of CCR5 and ERTR7 in multilocular mesenchymal cells in the aged thymus. Upper 
panels show histological sections of 21 month-old thymus containing CCR5-positive cells, by immunoperoxidase. 
Counterstaining was done with hematoxylin. Upper small panels on the right show CCR5+ multilocular cells inside the 
thymic parenchyma interacting with thymocytes and stromal cells. Lower panels show multilocular cells stained for ERTR7 
(red) and the nuclei dye DAPI (blue), by immunofluorescence. Black arrows indicate CCR5
+ multilocular cells. White arrows 
indicate ERTR7
+ multilocular cells. A, adipocyte; C, cortex; S, septae. Original magnification: Upper panels, 1000x; lower 
panels, 630x. 
 
 
Figure 5. CCR5 ligands mRNA expression in thymus and thymocytes of young and aged mice. cDNA ob-
tained from thymus (A) or total thymocytes (B) by reverse transcription using RNA isolated from 2- and 18-month-old mice 
were analyzed by real time RT-PCR. Specific primers to CCL3, CCL4 and CCL5 were utilized. The comparative threshold 
cycle (CT) method was utilized to calculate fold change (mean± SD) between age groups. Student’s t test (*p <0.05). Int. J. Med. Sci. 2010, 7 
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Figure 6. Increased expression of CCL4 and CCL5 in the thymus with age. Histological sections of thymus ob-
tained from 2 (A,D,G,J), 12 (B,E,H,L) and 18 (C,F,I,M) month-old mice were submitted to immunoperoxidase staining using 
rabbit-anti-CCL4 or anti-CCL5 antibodies. Counterstaining was done with hematoxylin. CCL4 and CCL5 were detected in 
thymocytes and stromal cells in the thymic parenchyma. Multilocular cells posi-
tively stained for CCL4 were seen in the thymic septa (H) and parenchyma (I) of 
mice with 12 and 18 months of age. Arrows indicate CCL4
+ cells resembling 
pericytes or multilocular mesenchymal cells in the septa region or inside the 
thymic parenchyma. C, cortex; M, medulla; P, parenchyma; S, septa; pe, pericytes. 
Original magnification: 630x (J-M); 1000x (A-I).  
 
Figure 7. Fat-storing multilocular cells in the thymus of 
CCR5-deficient mice. Frozen thymic sections were obtained from 10-11 
month-old CCR5-deficient mice (n=3). Histological sections were stained for Oil 
Red O to identify cells accumulating lipids. Oil Red O
+ cells were observed in the 
thymic parenchyma of control and CCR5-deficient mice (green arrows).  Int. J. Med. Sci. 2010, 7 
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Figure 8. CCR5 ligands promote adipocyte differentiation in vitro. (A) 3T3-L1 cells were fixed and stained, by 
immunofluorescence, with specific antibodies for mesenchymal cells, ERTR7 (red), and either CCR5 (green), CCL3 (green), 
CCL4 (green) or CCL5 (green) and the nuclei dye DAPI (blue). Insert shows DAPI and IgG control staining. (B) Confluent 
3T3-L1 cells were treated with 100 ng/ml of CCL3, CCL4 or CCL5 for 9 days. After, cell extracts were prepared and 
analyzed by Western blot using antibodies to the adipocyte differentiation markers PPARγ2 and aP2 as well as to β-actin, as 
loading control. (C) Increased number of cells differentiated towards adipocyte was observed in confluent 3T3-L1 cells 
cultured for 9 days (upper panel) and 12 days (lower panels), following treatment in the presence of CCR5 ligands. 
Chemokines were added every three days in culture media. Int. J. Med. Sci. 2010, 7 
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Figure 9. Migration of 3T3L1 preadipocytes is stimulated by CCR5 ligands in vitro. 3T3-L1 cells were grown to 
confluence on fibronectin-coated plates (A). The plates were then scratched utilizing a plastic tip (B) and treated or not (C, 
D) for 20 h with 100 ng/ml of CCL3 (E), CCL4 (F) or CCL5 (G, H). After 20h, control (D) and CCL-5 treated cell cultures 
(Panel H) were fixed and submitted to Nile Red and DAPI staining. Cells were observed in phase contrast (A-C, E-G) or 
under fluorescent microscopy (D, H). Migrating cells were observed in the space left by the scratch in the wells. Original 
magnification: 400x. 
 
Discussion 
Within the young thymus, several cell types 
have been described as playing a role in thymic 
physiology including thymocytes, thymic epithelial 
cells, dendritic cells, fibroblasts, mesenchymal cells 
and a variety of hematopoietic cells, such as macro-
phages, NK and B cells (25, 26). However, alterations 
in numbers, distribution and function of these thymic 
cellular components during the aging process are 
poorly known. In this work, we suggest that adipo-
cytes and fat-storing cells may be an active compo-
nent during thymic atrophy associated with age. In 
this context, unilocular adipocytic cells have been 
described to fill the space left by the receding lym-
phoid thymic compartment as thymus age (9, 27, 28). 
It is known that adipocyte deposition occurs in the 
aging thymus possibly due to the loss of thymopoiesis 
and increase of thymic interlobular spaces, character-
istics of thymic involution (10, 27, 28). In agreement, 
our histological analysis show progressive 
age-dependent alterations in the thymic organ, with 
unilocular adipocytes accumulation in the mouse 
thymic perivascular space (9, 27-29). In addition, our 
data also show interaction between unilocular adi-
pocytes with thymocytes and thymic stromal cells 
inside the thymic parenchyma. These observations 
suggest a possible functionality to adipocytic cells in 
the thymus which conflicts with the general belief that 
during aging, adipocytic unilocular cells simply fill a 
space left by the thymic lymphoid compartment or 
replace the lymphocytic perivascular space.  
In the present study, we defined not only thymic 
unilocular adipocytes in the thymus but also 
fat-storing multilocular mesenchymal cells, based on 
their morphology, Oil Red O and ERTR7 staining. We 
found that the presence of fat-storing cells inside the 
murine thymic parenchyma and septa region with age 
is in accordance with a previous study showing the 
ultrastructure of adipocytic multilocular cells in the 
thymus of rats and mouse (30). Interestingly, Oil Red 
O+ cells were shown within the perivascular space of 
human thymus (31). However, these authors failed to 
comment on the presence of adipogenic multilocular 
cells within the aged human thymus.  
An increased number of fat-storing multilocular 
cells within the aging thymus were also observed in 
our study. However, how these cells appear in the 
thymus and their function is unknown. We hypothe-
size at least three ways that these cells could appear in 
the organ. One hypothesis is that adipogenic multi-Int. J. Med. Sci. 2010, 7 
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locular cells could be differentiating from mesen-
chymal cells known to be present in the thymic pa-
renchyma since fetal life (32). It is also possible that 
fat-storing multilocular cells could be differentiating 
from pericytes associated with endothelial cells in 
blood capillaries of the thymus. In this context, peri-
cytes have the potential to differentiate to distinct 
mesenchymal cell lineages, including the adipocytic 
one (33, 34). Third, the immigration of adipocytic 
precursors from the perithymic adipose tissue or cir-
culation may result in adipocytic multilocular cell 
accumulation in the aging thymus. Recently, bone 
marrow mesenchymal stem cells were found to mi-
grate from the circulation to several tissues, including 
the thymus (35, 36). Finally, the possibility that all 
these events are happening conjointly during the 
process of aging cannot be ruled out. 
Our results show an age-associated increase in 
CCR5 mRNA expression in the thymus that correlates 
with an increased number of CCR5+ multilocular cells 
within the thymic capsule, septa and in the paren-
chyma of the organ. In this context, CCR5 expression 
has been previously found in human adipocytes in 
vitro and in human adipose tissue in situ as well as in 
3T3L1 preadipocyte line in culture (25, 37). Thus, the 
possibility that the chemokine receptor CCR5 could 
be regulating adipocyte migration was investigated. 
T o w a r d  t h i s  e n d ,  C C R 5  ligands mRNA expression 
increased in the aging thymus. The CCR5 ligands, 
CCL4 and CCL5, increase in the thymic parenchyma 
as revealed by the age-associated increases in the 
staining of thymocytes and microenvironmental cells, 
including the multilocular fat-storing cells. These data 
suggest that chemokines may influence the migration 
and possibly the differentiation of adipogenic or 
fat-storing cells within the aging thymus. However, 
our observations showing no significant differences in 
the number of fat-storing multilocular cells using 11 
month old CCR5-deficient versus wild type mice (al-
though a trend of lower adipocyte numbers was ob-
served) failed to support a role for CCR5 in adipocyte 
development in the aging thymus. However, these 
data also raised two possibilities. First, the progeni-
tors of these adipocyte-like cells could be thymic 
mesenchymal cells that are known to be present in the 
thymus parenchyma (31) and whose phenotype may 
be modified during the aging process. Second, other 
chemokine receptors could be acting in the migration 
of adipocytic mesenchymal cells to the aging thymus 
of CCR5-deficient mice. However, it should be noted 
that we were quite limited with the number of aged 
CCR5 deficient mice available to us to examine here 
and additional studies may provide more conclusive 
data regarding the role of distinct chemokine recep-
tors in adipogenic mesenchymal cell immigration 
and/or differentiation within the aging thymus.   
Interestingly, we have found that the CCR5 
ligands, CCL3, CCL4 and CCL5, without any other 
stimuli, were able to induce adipogenesis using the 
3T3-L1 mesenchymal cell line, as evaluated by the 
increased expression of PPARγ2 and aP2 (38, 39). To 
our knowledge, this is the first time CCR5 ligands are 
described to stimulate adipocyte differentiation. 
While these data do not directly demonstrate the 
ability of chemokine ligands to facilitate primary 
mesenchymal cell differentiation to the adipocyte 
lineage, these experiments support the idea that 
chemokines may be possibly acting as chemoattrac-
tants for adipogenic mesenchymal and/or fat-storing 
cells, facilitating their immigration and possibly their 
subsequent differentiation within the aging thymic 
microenvironment. Although additional work will be 
needed to establish a role for adipogenic cells in the 
thymus, several groups have shown thymic atrophy 
in transgenic mice harboring defects in adipocyte 
physiology, such as ob/ob (leptin), db/db (leptin re-
ceptor) and corticotropin-releasing factor overex-
p r e s s i n g  m i c e  ( 4 0 ,  4 1 ) .  I n  t h i s  c o n t e x t ,  r e d u c i n g  
proadipogenic signaling in caloric restriction model 
leads to a reduction in age-associated thymic involu-
tion (42). Obviously, much more work is needed to 
understand the crosstalk and interregulatory rela-
tionships between chemokines and cytokines, mes-
enchymal cells and adipocytes during the aging 
process, in particular during the thymic involution 
process. 
Adipocytes and preadipocytes secrete a number 
of inflammatory cytokines including LIF, IL-1, IL-6, 
TNF-α among others (43, 44). In the thymus, we have 
observed an increased level of LIF, IL-6, TNF-α and 
other pro-inflammatory cytokines in the supernatant 
of thymus explants of 10 month-old mice as compared 
to the thymus explants of 2 month-old animals (our 
unpublished data). In addition, the expression of LIF, 
oncostatin M and IL-6 increases in the thymus with 
age (8, 45). Thus, it is quite reasonable to hypothesize 
that the production of proinflammatory cytokines by 
adipocytic cells could actually contribute to oxidative 
stress in the thymus and, consequently, to the 
age-associated thymic involution process, killing 
thymocytes and/or thymic epithelial cells and favor-
ing the lipid accumulation in adipocytic cells. Our 
observations associating the increased presence of 
adipocytic/fat-storing mesenchymal cells and loss of 
thymocytes with advancing age lead to a novel con-
ceptual point of view concerning the understanding 
of the process of thymic physiology in aging, where 
the increase in adipocytes an fat-bearing cells may Int. J. Med. Sci. 2010, 7 
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play and active role in thymic tissue loss rather than 
simply increasing as a consequence of thymic loss by 
some other as-of-yet undescribed mechanism. Based 
on these findings, studies are underway to investigate 
the role of adipocytes and adipogenic precursors in 
the aging thymus physiology as well as their possible 
contribution to age-associated thymic involution. 
These studies may eventually lead to the develop-
ment of strategic therapies to improve thymic integ-
rity and thymopoiesis during aging. 
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